H
Hugues Legendre
Researcher at Institut Jules Bordet
Publications - 13
Citations - 657
Hugues Legendre is an academic researcher from Institut Jules Bordet. The author has contributed to research in topics: Cancer & Colorectal cancer. The author has an hindex of 8, co-authored 13 publications receiving 639 citations.
Papers
More filters
Journal ArticleDOI
Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting
Nathalie Nagy,Hugues Legendre,Olivier Engels,Sabine André,Herbert Kaltner,Kojiro Wasano,Yehiel Zick,Jean Claude Pector,Christine Decaestecker,Hans-Joachim Gabius,Isabelle Salmon,Robert Kiss +11 more
TL;DR: The current study analyzed the prognostic values contributed by galectin‐1, galECTin‐3, galect in‐4, and galectIn‐4 in cases of colon carcinoma to find out whether these values are related to prognostic value or not.
Journal ArticleDOI
Upregulation of galectins-1 and -3 in human colon cancer and their role in regulating cell migration
Axel-Benoit Hittelet,Hugues Legendre,Nathalie Nagy,Yves Bronckart,Jean Claude Pector,Isabelle Salmon,Paul Yeaton,Hans-Joachim Gabius,Robert Kiss,Isabelle Camby +9 more
TL;DR: Their expression significantly increased with the degree of dysplasia, suggesting that gal‐1 and gal‐3 and their binding sites are related to malignant progression, while gal‐8 has been associated with suppressor activity.
Journal ArticleDOI
Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor
Nathalie Nagy,Yves Bronckart,Isabelle Camby,Hugues Legendre,Harald Lahm,Herbert Kaltner,Yaron R. Hadari,P. Van Ham,Paul Yeaton,Jean Claude Pector,Yehiel Zick,Isabelle Salmon,André Danguy,Robert Kiss,Hans-Joachim Gabius +14 more
TL;DR: The present study deals with the quantitative determination of immunohistochemical expression of galectin-8 in normal, benign, and malignant human colon tissue samples and in four human colon cancer models maintained both in vitro as permanent cell lines and in vivo as nude mice xenografts.
Journal ArticleDOI
Prognostic Values of Galectin-3 and the Macrophage Migration Inhibitory Factor (MIF) in Human Colorectal Cancers
Hugues Legendre,Christine Decaestecker,Nathalie Nagy,Alain Hendlisz,Max-Peter Schüring,Isabelle Salmon,Hans-Joachim Gabius,Jean Claude Pector,Robert Kiss +8 more
TL;DR: MIF and galectin-3 expression levels in colorectal tumors are related to their levels of biological aggressiveness and could be used to identify patients at risk, for whom more aggressive adjuvant therapy seems to be indicated.
Journal ArticleDOI
Survival and quality of life after palliative surgery for neoplastic gastrointestinal obstruction
TL;DR: Palliative surgery can, in a certain number of cases, improve the quality of life of patients, but it has not been possible for us to demonstrate prognostic factors which would allow the selection of patients who could benefit the most from such surgery.